Betamethasone Sodium Phosphate BP
Whatsapp Order
Betamethasone Sodium Phosphate BP is a synthetic corticosteroid ester in its water-soluble sodium salt form. It is widely used for its strong anti-inflammatory and immunosuppressive properties in medical and veterinary applications. It is typically formulated as an injectable or ophthalmic solution to manage acute or chronic inflammatory and autoimmune conditions, including severe allergic reactions, asthma, arthritis, and dermatological disorders. Its rapid onset of action and high potency make it valuable in emergency and systemic therapy.
Description
Primary UsesÂ
Pharmaceutical Applications
- Injectable Corticosteroid: Used in intramuscular, intravenous, intra-articular, and intralesional injections for acute and severe inflammatory disorders (e.g., rheumatoid arthritis, lupus, multiple sclerosis, anaphylaxis).
- Endocrine Disorders: Used to treat adrenal insufficiency or congenital adrenal hyperplasia.
- Dermatologic Conditions: Effective in managing severe allergic dermatoses and skin conditions such as pemphigus or psoriasis.
- Respiratory Treatment: Used in the management of asthma and severe allergic rhinitis.
- Ophthalmic & Otic Preparations: Included in eye and ear drops to reduce inflammation caused by infections or injuries.
- Gastrointestinal Disorders: Administered for inflammatory bowel disease (Crohn’s disease, ulcerative colitis).
- Hematological Disorders: Used in the management of leukemias and lymphomas.
Veterinary Use
- Administered to animals for the treatment of inflammatory and allergic conditions in dogs, cats, and horses.
Secondary Uses
- Organ Transplantation: Occasionally used as part of immunosuppressive therapy post-transplant to prevent rejection.
- Adjunct Therapy: Combined with antibiotics to manage severe infections involving inflammation.
- Diagnostic Aid: Employed in adrenal function testing due to its corticosteroid action.
PRODUCT KEY FEATURES
. Basic Identification Attributes
- Chemical Name (IUPAC): Disodium (11β,16β)-9-fluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-21-yl phosphate
- Common/Trade Names: Betamethasone Sodium Phosphate, BSP, Celestone Phosphate
- CAS Number: 151-73-5
- HS Code: 2937.29.00
- Molecular Formula: C₂₂H₂₈FNa₂O₈P
- Synonyms:
- Betamethasone disodium phosphate
- Betamethasone 21-phosphate sodium
- BSP Sodium salt
2. Physical & Chemical Properties
- Physical State: White to off-white crystalline powder
- Color & Odor: Odorless; white to cream-colored
- Solubility: Freely soluble in water, slightly soluble in alcohol
- Melting Point: 220–230°C (with decomposition)
- pH (1% solution): ~7.0–9.0
- Stability: Stable under recommended storage; moisture sensitive
- Reactivity: Stable under normal conditions; avoid strong oxidizers
3. Safety & Hazard Attributes
- Hazard Class (GHS): Not classified as hazardous in diluted pharmaceutical use
- NFPA Ratings:
- Health: 2 (may cause organ effects with prolonged exposure)
- Flammability: 0
- Reactivity: 0
- Exposure Limits: No established OSHA/ACGIH limits
- Toxicity: Can cause adrenal suppression, immunosuppression, or metabolic effects with long-term or high-dose exposure
- Carcinogenicity: Not classified as carcinogenic
4. Storage & Handling Attributes
- Storage Conditions: Store at 15–25°C in airtight, moisture-proof containers
- Container Type: HDPE bottles, amber glass vials for solutions
- Shelf Life: 2–3 years (if stored properly)
- Special Handling: Avoid moisture and direct light; wear gloves and eye protection when handling bulk material
5. Regulatory & Compliance Attributes
- BP (British Pharmacopoeia): Complies with BP specifications for purity and assay
- FDA/EMA Status: Approved active pharmaceutical ingredient (API) in various formulations
- Transport Classification: Not classified as a hazardous substance for transport
- Waste Disposal: Dispose of according to local pharmaceutical waste regulations
6. Environmental & Health Impact
- Ecotoxicity: Not expected to be harmful in low environmental concentrations
- Persistence: Not readily biodegradable
- Bioaccumulation: Low potential
- Mutagenicity: No known mutagenic effects
- Endocrine Disruption: May affect hormone levels with prolonged environmental exposure
SAFETY HANDLING PRECAUTIONS
-
Safety Handling Precautions
- PPE: Use gloves, lab coat, and eye protection; use NIOSH-approved respirator for bulk powder.
- Dust Control: Avoid generation of dust; handle in fume hood or under local exhaust ventilation.
- Hygiene Measures: Avoid ingestion, inhalation, and skin contact. Wash hands thoroughly after handling.
- Spill Management: Collect spilled powder using damp cloth or HEPA vacuum; do not dry sweep.
First Aid Measures
- Inhalation: Remove to fresh air. Seek medical attention if respiratory symptoms persist.
- Skin Contact: Wash thoroughly with soap and water. Seek medical advice if irritation develops.
- Eye Contact: Rinse immediately with water for at least 15 minutes. Get medical attention.
- Ingestion: Rinse mouth. Seek medical advice, especially if large quantities are ingested.
Firefighting Measures
- Fire Hazards: Non-flammable; may decompose under fire to produce toxic fumes (e.g., carbon monoxide, fluorinated compounds).
- Extinguishing Media: Use water spray, foam, COâ‚‚, or dry chemical extinguishers.
- Protective Equipment: Firefighters should wear self-contained breathing apparatus (SCBA).
Special Notes: Prevent contaminated runoff from entering drains or water sources.
Related products
Cetirizine Hydrochloride (Cetirizine HCl)
Cetirizine Hydrochloride is a widely used second-generation antihistamine effective for treating allergic conditions such as allergic rhinitis, chronic urticaria, and other allergy symptoms. It is the hydrochloride salt form of cetirizine, existing as a white to off-white crystalline powder with a slightly bitter taste. Cetirizine HCl acts by selectively blocking peripheral H1 histamine receptors, thereby reducing allergic symptoms without significant sedation or central nervous system depression. It is commonly formulated into tablets, syrups, and capsules as an active pharmaceutical ingredient.
Chlorpheniramine Maleate
Chlorpheniramine Maleate is a first-generation alkylamine antihistamine used primarily to relieve allergy symptoms by blocking H1 histamine receptors. It appears as a white or off-white crystalline powder, freely soluble in water and alcohol. Known for rapid onset and moderate duration of action, it’s widely formulated in pharmaceuticals. It also exhibits mild anticholinergic and sedative effects.
Dicyclomine Hydrochloride (Dicyclomine HCL)
Dicyclomine Hydrochloride is an anticholinergic and antispasmodic agent used primarily to relieve smooth muscle spasms in the gastrointestinal tract. It works by blocking muscarinic receptors, thereby reducing muscle contractions and spasms, which helps alleviate symptoms of irritable bowel syndrome (IBS) and other functional bowel disorders. It is commonly available in oral tablets, capsules, and injectable formulations.
Doxycycline Hyclate BP
Doxycycline Hyclate BP is a broad-spectrum, semisynthetic tetracycline-class antibiotic available as the hemihydrate salt form of doxycycline. It is widely used in pharmaceutical formulations due to its high bioavailability, broad antibacterial activity, and favorable pharmacokinetic profile. The compound exhibits bacteriostatic action by inhibiting protein synthesis in susceptible bacteria, making it effective against a wide range of Gram-positive and Gram-negative organisms as well as atypical pathogens. It is typically supplied as a fine, white to off-white crystalline powder soluble in water and suitable for oral and parenteral dosage forms.
Hydrocortisone Base BP Micro
Hydrocortisone Base BP Micro is a highly purified, micronized form of hydrocortisone base compliant with British Pharmacopoeia (BP) standards. It is a white to off-white fine powder designed for enhanced solubility and bioavailability in pharmaceutical formulations. As a corticosteroid hormone analog, it exhibits potent anti-inflammatory, immunosuppressive, and anti-allergic activities. The micronized particle size (~93 microns) facilitates improved dispersion in topical, injectable, and oral dosage forms.
Lidocaine HCL BP
Lidocaine HCL BP is a white crystalline powder or granules that are highly soluble in water. It is a local anesthetic and antiarrhythmic agent widely used in medical and dental fields. Lidocaine HCL BP acts by blocking nerve signal transmission, providing rapid and effective numbing of targeted areas. It conforms to British Pharmacopoeia (BP) standards, ensuring pharmaceutical-grade purity and consistency. It is commonly formulated into injections, topical gels, creams, and patches for pain relief and arrhythmia treatment.
Metronidazole BP
Metronidazole Benzoate BP is a benzoate ester derivative of metronidazole, used primarily as an antiprotozoal and antibacterial agent. It is a prodrug that hydrolyzes in the body to release metronidazole, making it more palatable for pediatric and geriatric oral suspensions. It complies with the British Pharmacopoeia (BP) standards for purity and efficacy.
Piperazine Citrate BP
Piperazine Citrate BP is a pharmaceutical-grade anthelmintic compound used primarily for the treatment of intestinal worm infections, especially ascariasis (roundworms) and enterobiasis (pinworms). It works by paralyzing the worms, allowing them to be expelled naturally from the body through bowel movements. Piperazine Citrate is included in the British Pharmacopoeia (BP) and is known for its safety, efficacy, and wide use in both human and veterinary medicine.